| First Author | Takano T | Year | 2019 |
| Journal | Kidney Int | Volume | 95 |
| Issue | 1 | Pages | 57-61 |
| PubMed ID | 30612599 | Mgi Jnum | J:294238 |
| Mgi Id | MGI:6455098 | Doi | 10.1016/j.kint.2018.08.014 |
| Citation | Takano T, et al. (2019) Recessive mutation in CD2AP causes focal segmental glomerulosclerosis in humans and mice. Kidney Int 95(1):57-61 |
| abstractText | Although sequence variants in CD2-associated protein (CD2AP) have been identified in patients with focal segmental glomerulosclerosis (FSGS), definitive proof of causality in human disease is meager. By whole-exome sequencing, we identified a homozygous frame-shift mutation in CD2AP (p.S198fs) in three siblings born of consanguineous parents who developed childhood-onset FSGS and end stage renal disease. When the same frameshift mutation was introduced in mice by gene editing, the mice developed FSGS and kidney failure. These results provide conclusive evidence that homozygous mutation of CD2AP causes FSGS in humans. |
